QuidelOrtho says ‘confident’ in ability to deliver on revenue growth targets

Says strong performance across all geographies, including China. Remains “bullish” on China. Says China business “fine, expected to be a growth driver.” Expects high teens growth in China business in FY23. Says strong respiratory demand in key markets in Q3. Says strong order book, winning contracts. Says deleveraging remains a “key priority.” Says “very confident” of strong finish to year. Comments taken from Q3 earnings conference call.